Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. Since 1898, our doctors and scientists have been engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist.
Dr. Lorraine Gudas, chairman of the Department of Pharmacology and the Revlon Pharmaceutical Professor of Pharmacology and Toxicology, has been selected as a fellow of the American Society for Pharmacology and Experimental Therapeutics. This honor is given annually to individuals who have made major contributions both in research and in leadership in the pharmacology/chemical biology research community.
Dr. Parag Goyal, assistant professor of medicine and a heart failure cardiologist, has received The Paul B. Beeson Emerging Leaders Career Development Award in Aging. This prestigious research award is a 5-year grant in the amount of $1.1 million and will support development and testing of Dr. Goyal’s novel strategy for deprescribing medication in older adults with heart failure.